Olfr706 Inhibitors
Olfr706, a member of the olfactory receptor family in Mus musculus (house mouse), holds a vital role in the perception of odors. Similar to other olfactory receptors, Olfr706 belongs to the G-protein-coupled receptor (GPCR) family, characterized by a 7-transmembrane domain structure. These receptors are indispensable for recognizing odorant molecules and initiating neuronal responses through G protein-mediated transduction. In the mouse genome, the olfactory receptor gene family stands as the largest, underscoring its importance in the olfactory system. The nomenclature for olfactory receptor genes and proteins in mice is distinct from that of other organisms, emphasizing the unique diversity and functionality of these receptors.
Inhibition of Olfr706 can be achieved through various mechanisms, primarily focusing on indirect modulation due to the limited availability of direct inhibitors. Compounds such as Tetrodotoxin and Cycloheximide can influence Olfr706 by affecting neuronal signaling and protein synthesis, respectively. Additionally, inhibitors like Suramin and Propranolol, targeting GPCR signaling pathways, may indirectly impact Olfr706 function. Furthermore, compounds such as Wortmannin and LY294002 have the potential to inhibit Olfr706 by influencing the PI3K/Akt pathway, which can be involved in olfactory receptor signaling. These inhibitors offer promising avenues for research into controlling olfactory receptor responses in mice, contributing to a deeper understanding of the intricacies of olfaction. In conclusion, Olfr706 plays a pivotal role in the perception of odors in mice, standing as a significant member of the olfactory receptor gene family. Inhibition of Olfr706 can be achieved indirectly through various chemical compounds that influence GPCR signaling, protein synthesis, and associated intracellular pathways. Further exploration is needed to unravel the precise mechanisms of Olfr706 inhibition and their potential applications in deciphering the complexities of olfactory processes in mice.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is a protein synthesis inhibitor that could potentially affect Olfr706 indirectly by disrupting the synthesis of proteins involved in olfactory signaling pathways. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is a non-specific GPCR antagonist. It might indirectly inhibit Olfr706 by interfering with GPCR signaling, which plays a role in olfactory receptor function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase 4 (PDE4) inhibitor. By regulating cAMP levels, it may indirectly influence Olfr706, which is involved in cAMP-mediated signal transduction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3-kinase inhibitor. It may indirectly inhibit Olfr706 by affecting the PI3K/Akt pathway, which can be involved in olfactory receptor signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK1, a kinase in the MAPK pathway. Olfr706 may be indirectly modulated by this inhibitor, as it interacts with downstream components of this pathway. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
SQ22536 is an adenylate cyclase inhibitor, reducing cAMP levels. Olfr706, dependent on cAMP signaling, may be indirectly influenced by this compound. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3-kinase inhibitor, potentially affecting the PI3K/Akt pathway, which might indirectly modulate Olfr706, involved in cellular processes influenced by this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, part of the MAPK pathway. Olfr706 may be indirectly affected due to its association with this pathway. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a non-selective beta-blocker. It might indirectly affect Olfr706, as beta-adrenergic receptors are linked to GPCR signaling pathways that could interact with olfactory receptors. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gallein inhibits Gβγ-mediated signaling, which is crucial for olfactory receptor function. It could potentially affect Olfr706 by disrupting GPCR signaling pathways. | ||||||